Canaccord Genuity Group Initiates Coverage on Omada Health (NASDAQ:OMDA)

Canaccord Genuity Group started coverage on shares of Omada Health (NASDAQ:OMDA - Free Report) in a research report released on Tuesday, MarketBeat Ratings reports. The firm issued a buy rating and a $27.00 target price on the stock.

Separately, Wall Street Zen upgraded Omada Health to a "hold" rating in a research report on Monday, June 16th. One research analyst has rated the stock with a hold rating and seven have assigned a buy rating to the company's stock. Based on data from MarketBeat.com, the stock has an average rating of "Moderate Buy" and a consensus target price of $23.57.

Omada Health Price Performance

Shares of Omada Health stock traded up $0.53 during mid-day trading on Tuesday, hitting $18.63. The stock had a trading volume of 344,526 shares, compared to its average volume of 1,585,299. Omada Health has a 12-month low of $14.14 and a 12-month high of $28.40.

Omada Health Company Profile

Omada's mission is to bend the curve. Our hope is that, one day, tomorrow's epidemiologists will notice a bend in disease curves, wonder what might be happening, and conclude that part of that impact has been Omada. As part of that mission, we strive to inspire and enable people to make lasting health changes on their own terms.